Results for "Fisetin Senolytic" in Cancer

20 articles

New Senolytic Drugs Force Cancer's Zombie Cells to Self-Destruct
Cancer Research

New Senolytic Drugs Force Cancer's Zombie Cells to Self-Destruct

Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.

Press Release
May 13, 2026 0
Not All Zombie Cells Are Bad โ€” Precision Senolytic Therapy Is the Future of Anti-Aging
Cancer Research

Not All Zombie Cells Are Bad โ€” Precision Senolytic Therapy Is the Future of Anti-Aging

New research reveals senescent cells have both harmful and protective roles, pushing anti-aging science toward targeted removal strategies.

Press Release
May 22, 2026 0
Hepatitis C Drug Shows Promise Against Deadly Hepatitis E Virus
Cancer Research

Hepatitis C Drug Shows Promise Against Deadly Hepatitis E Virus

Bemnifosbuvir blocks hepatitis E replication in lab tests, offering hope for treating a virus that kills 70,000 people annually.

Press Release
Apr 7, 2026 0
Mirror Molecule Starves Cancer Cells While Sparing Healthy Tissue
Cancer Research

Mirror Molecule Starves Cancer Cells While Sparing Healthy Tissue

Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.

Press Release
Mar 28, 2026 1
DNA Therapy Slashes Bad Cholesterol by 50% Without Statin Side Effects
Cancer Research

DNA Therapy Slashes Bad Cholesterol by 50% Without Statin Side Effects

A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.

Press Release
May 2, 2026 0
New Molecule UNI418 Disables Cancer DNA Repair to Restore Drug Sensitivity
Cancer Research

New Molecule UNI418 Disables Cancer DNA Repair to Restore Drug Sensitivity

A small molecule called UNI418 shuts down cancer cells' DNA repair machinery, making drug-resistant tumors vulnerable to treatment again.

Press Release
Jun 11, 2026 0
Cholesterol Drug Evolocumab Cuts First Heart Attack Risk by 31% in Diabetics
Cancer Research

Cholesterol Drug Evolocumab Cuts First Heart Attack Risk by 31% in Diabetics

New study shows PCSK9 inhibitor prevents cardiovascular events in high-risk diabetes patients without existing heart disease.

Press Release
Apr 6, 2026 0
Single Protein Knockout Keeps Cancer-Fighting CAR T Cells Alive Longer
Cancer Research

Single Protein Knockout Keeps Cancer-Fighting CAR T Cells Alive Longer

Disabling the NFIL3 protein prevents CAR T cell exhaustion, boosting tumor-fighting power in animal models of hard-to-treat cancers.

Press Release
Jun 3, 2026 0
New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection
Cancer Research

New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection

Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.

Press Release
Mar 28, 2026 3
New Drug Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Breakthrough
Cancer Research

New Drug Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Breakthrough

A once-undruggable cancer driver has finally been targeted, cutting death risk by 60% in a landmark 500-patient trial.

Press Release
Jun 5, 2026 0
FDA Approves First Home-Use Device for Pancreatic Cancer Treatment
Cancer Research

FDA Approves First Home-Use Device for Pancreatic Cancer Treatment

Breakthrough non-invasive device offers new hope for pancreatic cancer patients with at-home treatment option.

Press Release
Apr 9, 2026 0
Whole Plant Foods Target All 10 Cancer Hallmarks Better Than Single Drugs
Cancer Research

Whole Plant Foods Target All 10 Cancer Hallmarks Better Than Single Drugs

Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.

Press Release
Mar 28, 2026 1
Scientists Discover Hidden Immune Brake SLAMF6 That Lets Cancer Escape Treatment
Cancer Research

Scientists Discover Hidden Immune Brake SLAMF6 That Lets Cancer Escape Treatment

A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within โ€” and blocking it may revive failed immunotherapies.

Press Release
Jun 11, 2026 0
AstraZeneca's In Vivo CAR-T Shows Promise Against Multiple Myeloma Despite Safety Concerns
Cancer Research

AstraZeneca's In Vivo CAR-T Shows Promise Against Multiple Myeloma Despite Safety Concerns

New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.

Press Release
Mar 28, 2026 1
Gut Microbes Drive Sleep Apnea Heart Risk Through Hidden Bile Acid Pathway
Cancer Research

Gut Microbes Drive Sleep Apnea Heart Risk Through Hidden Bile Acid Pathway

Mouse study reveals the FXR bile acid receptor links gut microbes to arterial plaque in sleep apnea, hinting at new preventive targets.

Press Release
Jun 11, 2026 0
Scientists discover why promising cancer drugs keep failing in patients
Cancer Research

Scientists discover why promising cancer drugs keep failing in patients

New research reveals why BET inhibitor cancer drugs work in labs but fail in patients, pointing to better treatment strategies.

Press Release
Apr 11, 2026 0
Scientists discover bone receptor that could prevent osteoporosis for life
Cancer Research

Scientists discover bone receptor that could prevent osteoporosis for life

New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.

Press Release
Apr 7, 2026 0
9-Week Immunotherapy Before Surgery Keeps Colon Cancer Patients Relapse-Free for 3 Years
Cancer Research

9-Week Immunotherapy Before Surgery Keeps Colon Cancer Patients Relapse-Free for 3 Years

A short pre-surgery course of pembrolizumab left zero relapses in colorectal cancer patients after 33 months โ€” reshaping treatment strategy.

Press Release
May 7, 2026 0
Supercharged Natural Killer Cells Crack Tumor Defenses in Aggressive Cancers
Cancer Research

Supercharged Natural Killer Cells Crack Tumor Defenses in Aggressive Cancers

McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.

Press Release
May 25, 2026 0
Modified Herpes Virus Breakthrough Transforms Brain Cancer Treatment
Cancer Research

Modified Herpes Virus Breakthrough Transforms Brain Cancer Treatment

Single injection of engineered virus kills glioblastoma cells and activates immune system, extending patient survival in clinical trial.

Press Release
Mar 28, 2026 4
Page 1 of 2Next